Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Segment Reporting Information, by Segment

The following table presents information about our segment revenue, segment profit or loss, and significant segment expenses (in thousands):


	Three months ended September 30,				Nine months ended September 30,
	2025		2024		2025		2024
REVENUES	$	536,990	$	589,131	$	1,690,558	$	1,752,241
Less:
Standard COGS(1)	230,728		296,622		773,952		878,052
Quality remediation/recall(2)	13,797		7,737		29,483		19,159
Other COGS(3)	91,584		79,920		268,069		257,506
Selling, general and administrative	152,773		162,707		469,398		479,913
Research and development	21,251		21,028		66,409		66,260
Restructuring and integration	13,138		16,828		46,053		50,069
Other segment items(4)	(5,997)		(5,070)		(53,623)		(4,842)
Interest expense	22,229		27,287		70,557		80,353
Income tax provision	(658)		15,055		5,090		19,631
Equity in losses (earnings) of unconsolidated affiliates	1,541		—		(1,296)		—
Consolidated net income (loss)	$	(3,396)	$	(32,983)	$	16,466	$	(93,860)

_______________

(1) Represents the average annual budgeted cost of producing each good sold in the period.

(2) Represents significant labor and material costs to replace or repair a product outside the scope of standard warranty and compliance costs related to quality systems and manufacturing operations.

(3) Includes costs related to capitalized manufacturing variances to standard COGS, supply chain and logistics costs including freight, inventory management and reserves, hardware service, quality and regulatory, and operations and supply chain management costs.

(4) Includes changes in fair value of contingent earn-out, interest income, gain/loss on disposition of assets, gain/loss on foreign exchange, other miscellaneous income/expense, and gain on sale of business.

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country

The table below presents our gross long-lived assets, consisting of property, plant and equipment, by country or region (in thousands):


	As of
	September 30, 2025		December 31, 2024
Costa Rica	163,685		156,149
Mexico	122,523		111,043
Other LATAM	67,330		55,451
Canada	1,903		5,284
Italy	34,979		29,124



Spain	20,048		17,141
Czech Republic	13,928		11,909
Other Europe	11,563		11,445
APAC	28,803		27,550
Total Foreign	$	464,762	$	425,096
United States*	626,827		610,547
Worldwide Total	$	1,091,589	$	1,035,643

________________________________

*As of December 31, 2024, we presented within the assets held for sale line item in our consolidated balance sheet, the gross long-lived assets that were part of a disposal group that met the criteria as held for sale during the fourth quarter of 2024 (See Note 4: Assets Held For Sale and Disposal of Business).

ICU MEDICAL INC/DE 10-Q